Auto-injectors are used for the administration of a single dose of a particular (typically life-saving) drug. They are designed for easy use and intended for self administration or administration by any untrained personnel.
This report provides an in-depth analysis of the global auto-injectors market. The stakeholders for this report include companies engaged in research and development, manufacturing, distribution, and commercialization of auto-injectors, and new entrants planning to invest in the auto-injectors market. The executive summary section of this report provides a snapshot of the auto-injectors market, which summarizes the market size, trends, and competition for different types of auto-injectors for various therapeutic applications on the global front.
The market overview section elucidates market dynamics such as drivers, restraints, and opportunities that currently have strong influence over the auto-injectors market and could impact the future scenario of the market as well. Market attractiveness analysis has been included in the market overview section in order to explicate the degree of competition among major geographies.
Porter’s five forces analysis is also incorporated in this section to explore the overall competition in the auto-injectors market, considering five different parameters that have an effect on the sustainability of companies in the market. The regulatory framework section highlights the standards and recommendations, set by various government organizations worldwide, which have strong impact on the auto-injectors market. Competition between major market players is analyzed along with their market share analysis in the competitive landscape section of the report. Value chain analysis has been provided to recognize the value-creating activities from a number of processes that take place in transforming inputs to valuable outputs. Event mapping is done for a brief understanding of the technological advancements, new product launches, and strategic decisions taken by players in the global auto-injectors market. All these factors assist the market players in taking strategic decisions, which help them in escalating their market share and strengthening their positions in the global auto-injectors market.
The global auto-injectors market has been segmented on the basis of product, therapeutic applications, and manufacturing design. Based on product type, the global auto-injectors market is classified into two major segments, namely prefilled auto-injectors and fillable auto-injectors. Based on therapeutic applications, the auto-injectors market is differentiated into four segments: anaphylaxis, multiple sclerosis, rheumatoid arthritis, and others. Depending upon the manufacturing design, the global auto-injectors market is categorized into two segments: standardized auto-injectors and customized auto-injectors. Market revenue in terms of USD million for the period between 2012 and 2020 along with the compound annual growth rate (CAGR %) from 2014 to 2020 are provided for all segments, considering 2013 as the base year.
Geographically, the global auto-injectors market has been segmented into four regional markets: North America, Europe, Asia Pacific, and Rest of the World (RoW). This section of the report provides market estimations in terms of revenue (USD million) of auto-injectors across four regions from 2012 to 2020. CAGR % for the period from 2014 to 2020 is also analyzed for these four geographies, considering 2013 as the base year.
This report also includes recommendations that would help new market entrants in establishing presence and existing market players in expanding their global reach and market share in the auto-injectors market. The report concludes by profiling major players in the auto-injectors market. Company overview, financial overview, product portfolio, business strategy, and recent developments are provided for major market players in the company profile section. Major market players profiled in the report include Antares Pharma, Inc., Becton, Dickinson and Company, Biogen Idec, Inc., Mylan, Inc., Novartis International AG, Pfizer, Inc., Sanofi, Scandinavian Health Limited (SHL) Group, Unilife Corporation, and Ypsomed Holdings AG.
The global auto-injectors market has been segmented into the following categories:
Global Auto-Injectors Market, by Product Type
- Prefilled (Disposable) Auto-injectors
- Fillable (Reusable) Auto-injectors
Global Auto- Injectors Market, by Therapeutic Application
- Multiple Sclerosis
- Rheumatoid Arthritis
Global Auto-Injectors Market, by Product Type
- Standardized Auto-injectors
- Customized Auto-injectors
Global Auto-Injectors Market, by Geography
- North America
- Asia Pacific
- Rest of the World (RoW)